43 research outputs found
Bilateral giant femoropopliteal artery aneurysms: a case report
<p>Abstract</p> <p>Introduction</p> <p>Popliteal artery aneurysms are the most common peripheral arterial aneurysms, and are frequently bilateral. Acute limb ischemia, rupture and compression phenomena can complicate these aneurysms when the diameter exceeds 2 cm.</p> <p>Case Presentation</p> <p>We report an 82-year-old male patient with two giant femoropopliteal aneurysms, 10.5 and 8.5 cm diameters, managed in our institution. Both aneurysms were resected and a polytetrafluoroethylene (PTFE) femoropopliteal interposition graft was placed successfully. Management and literature review are discussed.</p> <p>Conclusion</p> <p>We believe this is the first report in the medical literature of bilateral giant femoropopliteal aneurysms.</p
Hepatic abscess in a pre-existed simple hepatic cyst as a late complication of sigmoid colon ruptured diverticula: a case report
<p>Abstract</p> <p>Introduction</p> <p>Hepatic abscesses have been reported as a rare complication of diverticulitis of the bowel. This complication is recognized more commonly at the time of the diagnosis of diverticulitis, or ruptured diverticula, but also can be diagnosed prior to surgery, or postoperatively.</p> <p>Case presentation</p> <p>This report describes a man who developed an hepatic abscess within a simple hepatic cyst, two months after operation for ruptured diverticula of the sigmoid colon. The abscess was drained surgically and the patient made a complete recovery.</p> <p>Conclusion</p> <p>The development of an hepatic abscess in a pre-existing hepatic cyst, secondary to diverticulitis, is a rare complication. A high degree of clinical suspicion is required for immediate diagnosis and treatment.</p
The Hypothesis Regarding the Benefit of Carotid Endarterectomy Under Locoregional Anesthesia in Prevention of Stroke May be Unanswered
A recent trial attempted to investigate the role of locoregional
anesthesia (LA) in carotid endarterectomy (CEA) compared with general
anesthesia. The hypothesis regarding the advantage of LA is based on the
intraprocedural neurologic evaluation and the early identification of
neurologic deficit. The trial has not demonstrated the superiority of
the rocoregional anesthesia versus general anesthesia and revealed equal
results concerning the prevention of stroke. We analyze the reasons
which explain why the hypothesis regarding the advantage of LA in CEA,
in comparison to general anesthesia cannot be answered
An update on markers of carotid atherosclerosis in patients with Type 2 diabetes
Carotid atherosclerosis constitutes an important cause of ischemic brain
attack and stroke, accounting for up to 40% of cases of ischemic
cerebrovascular disease. Type 2 diabetes mellitus is an independent risk
factor for stroke and its recurrence. Thus, identifying diabetic
patients who are at high risk of developing stroke is of great clinical
importance. Noninvasive measurements of surrogate markers of
atherosclerosis, such as novel serum biomarkers, can be helpful in
detecting subclinical carotid disease, especially among individuals at
the highest cardio-/cerebro-vascular risk. Previous studies have
proposed an expanding body of serum biomarkers, such as C-reactive
protein, fibrinogen, adipokines, cytokines and growth factors, as novel
indicators of carotid atherosclerosis development that predict
carotid-related clinical outcomes. Furthermore, those biomarkers are
expected to assess the efficacy of both pharmaceutical and
interventional strategies. Accordingly, it is increasingly clear that
measuring biomarkers may improve the definition of cerebrovascular risk
profile in patients with Type 2 diabetes mellitus
What a vascular surgeon should know and do about atherosclerotic risk factors
Atherosclerosis is a systematic disease presenting with a significant
overlapping of cardiovascular disorders implicating coronary heart
disease and its equivalents, peripheral arterial disease, carotid
arterial disease, and aneurysm disease. Evaluating patient’s
atherosclerotic risk profile is essential to guide primary and secondary
prevention. Atherosclerotic risk factor modifications reduce,
significantly, cardiovascular disease mortality and morbidity,
particularly in high-risk patients. This article provides a reference
guide for all conventional (eg, smoking, dyslipidemia, hypertension) and
evolving (eg, homocysteine, C-reactive protein, fibrinogen, inflammatory
markers) risk factors of atherosclerosis and recommends the currently
effective strategies for an overall cardiovascular risk reduction. As
vascular surgeons, by definition, conduct the overall management of
patients with vascular disease understanding of the development,
assessment, and management of atherosclerotic risk factors should remain
among their highest priorities. (J Vasc Surg 2009;49:1348-54.